CymaBay Therapeutics, Inc.

DIMENSIONAL FUND ADVISORS LP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/7/2024

Shares

1,161,964

Value ($000)

27,447

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/7/2024	27,447	0.0%	1,161,964	12/31/2023
2023 Q3	11/9/2023	17,327	0.0%	1,161,964	9/30/2023
2023 Q2	8/9/2023	12,773	0.0%	1,167,413	6/30/2023
2023 Q1	5/12/2023	10,319	0.0%	1,183,236	3/31/2023
2022 Q4	2/9/2023	8,242	0.0%	1,314,522	12/31/2022
2022 Q3	11/10/2022	4,366	0.0%	1,247,365	9/30/2022
2022 Q2	8/12/2022	3,179	0.0%	1,077,686	6/30/2022
2022 Q1	5/13/2022	2,926	0.0%	940,806	3/31/2022
2021 Q4	2/9/2022	2,686	0.0%	794,841	12/31/2021
2021 Q3	11/12/2021	2,840	0.0%	778,115	9/30/2021
2021 Q2	8/12/2021	5,063	0.0%	1,161,109	6/30/2021
2021 Q1	5/14/2021	6,002	0.0%	1,322,192	3/31/2021
2020 Q4	3/8/2021	7,187	0.0%	1,251,986	12/31/2020
2020 Q3	11/12/2020	7,563	0.0%	1,044,735	9/30/2020
2020 Q2	8/13/2020	3,177	0.0%	910,303	6/30/2020
2020 Q1	5/14/2020	1,568	0.0%	1,059,531	3/31/2020
2019 Q4	2/14/2020	2,144	0.0%	1,093,885	12/31/2019